NCT04962022 Drug-Drug Interaction Study Assessing Effect of Itraconazole on PF-07321332/Ritonavir in Healthy Participants Status COMPLETED Phase PHASE1
NCT04960202 EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19 Status COMPLETED Phase PHASE2/PHASE3
NCT04955626 To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age. Status COMPLETED Phase PHASE3
NCT04951323 Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo) Status UNKNOWN Phase PHASE3
NCT04937660 Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBC Status COMPLETED Phase N/A
NCT04935879 A Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive Crises Status COMPLETED Phase PHASE3
NCT04933799 IRAK 4 Inhibitor (PF-06650833) in Hospitalized Patients With COVID-19 Pneumonia and Exuberant Inflammation. Status UNKNOWN Phase PHASE2
NCT04930445 Oxbryta® Product Registry An Observational Study Designed to Evaluate the Effect of Oxbryta in Individuals With SCD Status TERMINATED Phase N/A
NCT04930328 Retrospective Real World Oxbryta® Data Collection and Analysis Study Status COMPLETED Phase N/A
NCT04927312 Study to Assess Efficacy and Safety of PF-06947386 in Japanese Adult Patients With Complicated Intra-abdominal Infection Status COMPLETED Phase PHASE3
NCT04927247 A Study of a Single Dose of Inclacumab to Reduce Re-admission in Participants With Sickle Cell Disease and Recurrent Vaso-occlusive Crises Status TERMINATED Phase PHASE3
NCT04920708 Fulvestrant, Ipatasertib and CDK4/6 Inhibition in Metastatic ER+/HER2- Breast Cancer Patients Without ctDNA Suppression Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04919122 Outcomes Database to prospectivelY aSSEss the Changing TherapY Landscape in Renal Cell Carcinoma Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04916795 A Study To Investigate The Pharmacokinetics, Pharmacodynamics, Safety And Tolerability Of Single Dose Vupanorsen In Healthy Chinese Adults Status COMPLETED Phase PHASE1
NCT04916769 Bioavailability of Bosutinib Administered as Capsule Contents Mixed With Applesauce or Yogurt Relative to Intact Capsules Under Fed Condition Status COMPLETED Phase PHASE1
NCT04916509 Treatment Patterns and Clinical Outcomes Among Patients Receiving Palbociclib Combinations for Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2 ) Advanced/Metastatic Breast Cancer in the Arabian Gulf Region Status COMPLETED Phase N/A
NCT04915950 A Study to Assess the Effect of Oral Temanogrel on Digital Blood Flow in Adult Participants With Raynaud's Phenomenon Secondary to Systemic Sclerosis Status TERMINATED Phase PHASE2
NCT04909853 Renal Impairment Study of PF-07321332 Boosted With Ritonavir in Adult Participants With Renal Impairment and in Healthy Participants With Normal Renal Function. Status COMPLETED Phase PHASE1